Citadel Advisors LLC Takes $662,000 Position in NYLI Candriam U.S. Mid Cap Equity ETF (NYSEARCA:IQSM)

Citadel Advisors LLC purchased a new stake in shares of NYLI Candriam U.S. Mid Cap Equity ETF (NYSEARCA:IQSMFree Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 20,406 shares of the company’s stock, valued at approximately $662,000. Citadel Advisors LLC owned about 0.30% of NYLI Candriam U.S. Mid Cap Equity ETF at the end of the most recent reporting period.

Separately, Seeds Investor LLC lifted its position in shares of NYLI Candriam U.S. Mid Cap Equity ETF by 6.1% in the fourth quarter. Seeds Investor LLC now owns 44,485 shares of the company’s stock worth $1,444,000 after buying an additional 2,547 shares during the last quarter.

NYLI Candriam U.S. Mid Cap Equity ETF Price Performance

Shares of NYSEARCA:IQSM opened at $31.57 on Friday. The stock has a market capitalization of $208.36 million, a P/E ratio of 20.02 and a beta of 1.26. The business has a 50-day moving average of $30.09 and a two-hundred day moving average of $32.06. NYLI Candriam U.S. Mid Cap Equity ETF has a fifty-two week low of $26.78 and a fifty-two week high of $35.34.

NYLI Candriam U.S. Mid Cap Equity ETF Company Profile

(Free Report)

The Iq Candriam ESG U.S. Mid Cap Equity ETF (IQSM) is an exchange-traded fund that is based on the IQ Candriam ESG U.S. Mid Cap Equity index. The fund tracks a market cap-weighted index that provides exposure to US mid-cap stocks that meet environmental, social, and corporate governance criteria. IQSM was launched on Oct 25, 2022 and is managed by IndexIQ.

Featured Stories

Want to see what other hedge funds are holding IQSM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NYLI Candriam U.S. Mid Cap Equity ETF (NYSEARCA:IQSMFree Report).

Receive News & Ratings for NYLI Candriam U.S. Mid Cap Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NYLI Candriam U.S. Mid Cap Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.